Enanta Pharmaceuticals, Inc. Announces Financial Results for the Second Fiscal Quarter and Six Months Ended March 31, 2013

Published: May 08, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today reported financial results for its second fiscal quarter and six months ended March 31, 2013.

Help employers find you! Check out all the jobs and post your resume.

Back to news